Position
SIMPLEX TRADING, LLC in Iovance Biotherapeutics, Inc.
Back to the book · All holders of IOVA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $118.4K$2.73 → $3.51
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 329.1K | $898.3K | — | — | — | 0.0% |
| Q1 2026 | 151.8K | $532.9K | $3.51 | $118.4K | −$483.8K | 0.0% |